P-ALAXIN

This brand name is authorized in Nigeria.

Active ingredients

The drug P-ALAXIN contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 6A9O50735X - ARTENIMOL
 

Artemisinin is used in the treatment of malaria due to species Plasmodium.

 
Read more about Artemisinin
2
UNII 854D7K8LXB - PIPERAQUINE PHOSPHATE
 
Read more about

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100810 Tablet P-ALAXIN DS TABLET TAB 80 mg; 640 mg 10 x 1 x 6 64 NF-PP-408941 P-ALAXIN DS TABLET DIHYDROARTEMISININ 80MG & PIPERAQUINE PHOSPHATE 640MG DIHYDROARTEMISININ 80MG & PIPERAQUINE PHOSPHATE 640MG, PREGELATINISED STARCH BP 219.1MG, MALTODEXRIN BP 40MG, CROSCARMELLOSE SODIUM BP 80.12MG, MAGNESIUM STERATE BP 10.76MG, WINCOAT WT-01215 BLUE IH 36MG, ISOPROPYL ALCOHOL BP, DICHLOROMETHANE BP, PURIFIED TALC BP A4-100810 Drugs Imported Products 10 x 1 x 6 Over The Counter (OTC) GREENLIFE PHARMACEUTICALS LIMITED, 35A, ASSOCIATION AVENUE, ILUPEJU, LAGOS 17378995 greenlife.regulatory@yahoo.com BLISS GVS PHARMA LIMITED, PLOT NO 10, 11-A,12, SURVEY NO 38/1, DEWAN UDYOG NAGAR, ALIYALI VILLAGE, MAHARASHTRA STATE,INDIA, India 30/04/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
P01BF05 Artenimol and piperaquine P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100810

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.